Pharmacological prevention and early treatment of post-traumatic stress disorder and acute stress disorder: a systematic review and meta-analysis
- PMID: 31819037
- PMCID: PMC6901463
- DOI: 10.1038/s41398-019-0673-5
Pharmacological prevention and early treatment of post-traumatic stress disorder and acute stress disorder: a systematic review and meta-analysis
Abstract
Post-traumatic stress disorder (PTSD) is a common mental disorder associated with significant distress and reduced functioning. Its occurrence after a severe traumatic event and association with characteristic neurobiological changes make PTSD a good candidate for pharmacological prevention and early treatment. The primary aim for this systematic review and meta-analysis was to assess whether pharmacological interventions when compared to placebo, or other pharmacological/psychosocial interventions resulted in a clinically significant reduction or prevention of symptoms, improved functioning or quality of life, presence of disorder, or adverse effects. A systematic search was undertaken to identify RCTs, which used early pharmacotherapy (within three months of a traumatic event) to prevent and treat PTSD and acute stress disorder (ASD) in children and adults. Using Cochrane Collaboration methodology, RCTs were identified and rated for risk of bias. Available data was pooled to calculate risk ratios (RR) for PTSD prevalence and standardised mean differences (SMD) for PTSD severity. 19 RCTs met the inclusion criteria; 16 studies with adult participants and three with children. The methodological quality of most trials was low. Only hydrocortisone in adults was found to be superior to placebo (3 studies, n = 88, RR: 0.21 (CI 0.05 to 0.89)) although this was in populations with severe physical illness, raising concerns about generalisability. No significant effects were found for the other pharmacotherapies investigated (propranolol, oxytocin, gabapentin, fish oil (1470 mg DHA/147 mg EPA), fish oil (224 mg DHA/22.4 mg EPA), dexamethasone, escitalopram, imipramine and chloral hydrate). Hydrocortisone shows the most promise, of pharmacotherapies subjected to RCTs, as an emerging intervention in the prevention of PTSD within three months after trauma and should be a target for further investigation. The limited evidence for hydrocortisone and its adverse effects mean it cannot be recommended for routine use, but, it could be considered as a preventative intervention for people with severe physical illness or injury, shortly after a traumatic event, as long as there are no contraindications. More research is needed using larger, high quality RCTs to establish the most efficacious use of hydrocortisone in different populations and optimal dosing, dosing window and route. There is currently a lack of evidence to suggest that other pharmacological agents are likely to be effective.
Conflict of interest statement
The authors declare that they have no conflict of interest.
Figures
Similar articles
-
Early pharmacological interventions for prevention of post-traumatic stress disorder (PTSD) in individuals experiencing acute traumatic stress symptoms.Cochrane Database Syst Rev. 2024 May 20;5(5):CD013613. doi: 10.1002/14651858.CD013613.pub2. Cochrane Database Syst Rev. 2024. PMID: 38767196 Review.
-
Early pharmacological interventions for universal prevention of post-traumatic stress disorder (PTSD).Cochrane Database Syst Rev. 2022 Feb 10;2(2):CD013443. doi: 10.1002/14651858.CD013443.pub2. Cochrane Database Syst Rev. 2022. PMID: 35141873 Free PMC article. Review.
-
Psychological and pharmacological interventions for posttraumatic stress disorder and comorbid mental health problems following complex traumatic events: Systematic review and component network meta-analysis.PLoS Med. 2020 Aug 19;17(8):e1003262. doi: 10.1371/journal.pmed.1003262. eCollection 2020 Aug. PLoS Med. 2020. PMID: 32813696 Free PMC article.
-
Pharmacological prevention of post-traumatic stress disorder and acute stress disorder: a systematic review and meta-analysis.Lancet Psychiatry. 2015 May;2(5):413-421. doi: 10.1016/S2215-0366(14)00121-7. Epub 2015 Apr 28. Lancet Psychiatry. 2015. PMID: 26360285 Review.
-
Multiple session early psychological interventions for the prevention of post-traumatic stress disorder.Cochrane Database Syst Rev. 2019 Aug 8;8(8):CD006869. doi: 10.1002/14651858.CD006869.pub3. Cochrane Database Syst Rev. 2019. PMID: 31425615 Free PMC article.
Cited by
-
Impact of healthcare interventions on distress following acute musculoskeletal/orthopaedic injury: a scoping review of systematic reviews.BMJ Open. 2024 Jul 18;14(7):e085778. doi: 10.1136/bmjopen-2024-085778. BMJ Open. 2024. PMID: 39025825 Free PMC article. Review.
-
Early pharmacological interventions for prevention of post-traumatic stress disorder (PTSD) in individuals experiencing acute traumatic stress symptoms.Cochrane Database Syst Rev. 2024 May 20;5(5):CD013613. doi: 10.1002/14651858.CD013613.pub2. Cochrane Database Syst Rev. 2024. PMID: 38767196 Review.
-
Preventing Post Traumatic Stress Disorder in the general population induced by trauma during the COVID pandemic: A simple brief intervention based on cognitive science that could be delivered digitally.Eur J Trauma Dissociation. 2021 May;5(2):100193. doi: 10.1016/j.ejtd.2020.100193. Epub 2020 Dec 30. Eur J Trauma Dissociation. 2021. PMID: 38620807 Free PMC article.
-
Therapeutic uses of oxytocin in stress-related neuropsychiatric disorders.Cell Biosci. 2023 Nov 28;13(1):216. doi: 10.1186/s13578-023-01173-6. Cell Biosci. 2023. PMID: 38017588 Free PMC article. Review.
-
Post-traumatic stress disorder: a psychiatric disorder requiring urgent attention.Med Rev (2021). 2022 Aug 2;2(3):219-243. doi: 10.1515/mr-2022-0012. eCollection 2022 Jun. Med Rev (2021). 2022. PMID: 37724188 Free PMC article. Review.
References
-
- Breslau N. The epidemiology of posttraumatic stress disorder: what is the extent of the problem? J. Clin. Psychiatry. 2001;62(Suppl 17):16–22. - PubMed
-
- American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders 5th edn (Washington, DC, 2013).
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous